We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Breaking Barriers with #MSVisibility

Breaking Barriers with #MSVisibility

#MSVisibility 2022 kicks off with a focus on empowering the Hispanic / Latinx community to break through cultural barriers to early and appropriate care that can delay disease progression in multiple sclerosis (MS).